Description

Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is president and CEO of Novocell, a La Jolla-based company that has been developing a potential therapy for diabetes. Novocell has a CIRM grant to assemble a team of researchers who will accelerate the time it takes to get that potential therapy to the FDA for clinical trials.

Video URL:
http://www.allthingsscience.com/video/272/Alan-Lewis-Embryonic-Stem-Cell-Therapies-for-diabetes


Embed URL
<object width="" height=""><param name="movie" value="http://www.allthingsscience.com/nvlab/player/player.swf?config=http://www.allthingsscience.com/nvlab/econfig.php?key=25499f1680b9896beede"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><param name="wmode" value="transparent"></param><embed src="http://www.allthingsscience.com/nvlab/player/player.swf?config=http://www.allthingsscience.com/nvlab/econfig.php?key=25499f1680b9896beede" type="application/x-shockwave-flash" allowscriptaccess="always" allowfullscreen="true" wmode="transparent" width="" height=""></embed></object>